ImmunoGen

Job Listings

Here are our current client job openings. Please view the details for more information, and apply from that page if you are interested.

Use this form to do another job search

The system cannot access your location for 1 of 2 reasons:
  1. Permission to access your location has been denied. Please reload the page and allow the browser to access your location information.
  2. Your location information has yet to be received. Please wait a moment then hit [Search] again.
Click column header to sort

Search Results Page 1 of 1

Posted Date 4 weeks ago(6/29/2021 2:03 PM)
ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.” Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1798
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 1 month ago(6/11/2021 3:15 PM)
Who We AreImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1796
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 2 months ago(5/26/2021 8:54 AM)
Who We AreImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.” Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1794
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 2 months ago(5/13/2021 4:04 PM)
Who We AreImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1792
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 2 months ago(5/12/2021 2:55 PM)
Who We AreImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1791
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 2 months ago(5/11/2021 8:22 AM)
Who We AreImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1790
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 3 months ago(5/7/2021 3:35 PM)
Who We AreImmunoGen is a clinical-stage biotechnology company that develops targeted anticancer therapeutics with its proprietary antibody-drug conjugate (ADC) technology. The Company's lead product candidate, mirvetuximab soravtansine, is a potential treatment for folate receptor α-positive ovarian cancers and other solid tumors. Leading healthcare companies have licensed rights to use ImmunoGen's technology to develop novel anticancer therapies, and Roche's marketed product, Kadcylaďź…, utilizes ImmunoGen's ADC technology. More information about the Company can be found at www.immunogen.com.
Job ID
2021-1788
Job Locations
US-MA-Waltham
Territory
Waltham, MA
Posted Date 3 months ago(5/7/2021 3:35 PM)
Who We AreImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Job ID
2021-1789
Job Locations
US-MA-Waltham
Territory
Waltham, MA